Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Marker, Biological”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableUnknownNCT04638868
What this trial is testing

Silicon Microsieve Device vs Cell Surface Marker-based Platform for the Isolation of Pancreatic Cancer CTCs

Who this might be right for
Pancreatic Cancer
Singapore General Hospital 26
Not applicableStudy completedNCT01495390
What this trial is testing

A Longitudinal Study of Amyotrophic Lateral Sclerosis (ALS) Biomarkers

Who this might be right for
Amyotrophic Lateral SclerosisNervous System DiseasesSclerosis+6 more
Massachusetts General Hospital 139
Not applicableStudy completedNCT03316508
What this trial is testing

Copeptin- Relevance as a Perioperative Marker in Pediatric Cardiac Surgery

Who this might be right for
Congenital Heart Disease
Claudia Herbst 81
Not applicableNot Yet RecruitingNCT07393217
What this trial is testing

Correlation Between Circulating Fibroblast Activation Protein (FAP) and Fibrosis in Two Diseases (Rheumatoid Arthritis and Systemic Sclerosis)

Who this might be right for
Rheumatoid Arthritis (RA)Systemic Sclerosis (SSc)
Sohag University 111
Not applicableStudy completedNCT01596790
What this trial is testing

COLOSPOT Study : Assessment by EPISPOT of Circulating Tumor Cells in Patients With Metastatic Colorectal Cancer

Who this might be right for
Metastatic Colorectal Cancer
University Hospital, Montpellier 168
Not applicableStudy completedNCT02184676
What this trial is testing

T1D Risk Assessment in Kids With Relatives

Who this might be right for
Type 1 Diabetes
Assistance Publique - Hôpitaux de Paris 512
Not applicableUnknownNCT03938597
What this trial is testing

Investigation of Serious Adverse Events Following Vaccination Against Yellow Fever: Emphasis on Genetic Basis and Biological Markers

Who this might be right for
Drug-Related Side Effects and Adverse Reactions
The Immunobiological Technology Institute (Bio-Manguinhos) / Oswaldo Cruz Foundation (Fiocruz) 10
Not applicableStudy completedNCT04586582
What this trial is testing

ST-Segment Resolution as a Marker for Myocardial Scar in ST-Segment Elevation Myocardial Infarction

Who this might be right for
Cardiovascular Diseases
Chongqing Medical University 42
Not applicableStudy completedNCT03238040
What this trial is testing

Biomarkers of Acute Serious Illness in Children

Who this might be right for
Critical IllnessInfection, MixedChildren, Only
Great Ormond Street Hospital for Children NHS Foundation Trust 674
Not applicableUnknownNCT06486350
What this trial is testing

IL-6: A Marker for AML Chemo Sensitivity

Who this might be right for
AML, Adult
Fujian Medical University Union Hospital 72
Post-approval studies (Phase 4)UnknownNCT03187093
What this trial is testing

Cognitive Dysfunction in MDD Patients

Who this might be right for
Major Depressive Disorder
Oleg Levada 150
Not applicableLooking for participantsNCT06818149
What this trial is testing

Biomarkers for Clinical Classification and Outcomes of Immune Checkpoint Inhibitor-Related-Related Myocarditis in Lung Cancer

Who this might be right for
Lung CancerMyocarditis Due to Drug
Shanghai Chest Hospital 50
Not applicableNot Yet RecruitingNCT07406126
What this trial is testing

Yttrium-90 Radioembolization Neoadjuvant Therapy With Immune Marker Profiling and Dosimetry for Potentially Resectable Patients With Colorectal Liver Metastases

Who this might be right for
Colorectal Liver Metastases (CRCLM)Unresectable Colorectal Liver Metastases
Fernando Gómez Muñoz 30
Testing effectiveness (Phase 2)Study completedNCT00602043
What this trial is testing

F-18 16 Alpha-Fluoroestradiol-Labeled Positron Emission Tomography in Predicting Response to First-Line Hormone Therapy in Patients With Stage IV Breast Cancer

Who this might be right for
Estrogen Receptor-positive Breast CancerProgesterone Receptor-negative Breast CancerProgesterone Receptor-positive Breast Cancer+2 more
National Cancer Institute (NCI) 20
Post-approval studies (Phase 4)Study completedNCT02492217
What this trial is testing

Biomarkers Identification of Anti-tumor Necrosis Factor (TNF) α Agent's Efficacy in Ankylosing Spondylitis Patients

Who this might be right for
Ankylosing Spondylitis
Universidade Nova de Lisboa 69
Testing effectiveness (Phase 2)Study completedNCT01387880
What this trial is testing

Irinotecan, Cetuximab and Everolimus to Patients With Metastatic Colorectal Cancer

Who this might be right for
Metastatic Colorectal Cancer
Herlev Hospital 100
Post-approval studies (Phase 4)Study completedNCT00391690
What this trial is testing

Evaluation of Bone Markers as Diagnostic Tools for Early Detection of Bone Metastases in Patients With High Risk Prostate Cancer

Who this might be right for
Prostate Cancer
Novartis 99
Early research (Phase 1)Study completedNCT00707343
What this trial is testing

[F-18] Fluorothymidine (FLT) Imaging on Patients With Primary Brain Tumors

Who this might be right for
CancerBrain Tumors
University of Utah 15
Not applicableUnknownNCT03984084
What this trial is testing

Biological Classification of Mental Disorders

Who this might be right for
Mental DisorderDepressive DisorderAnxiety+1 more
Max-Planck-Institute of Psychiatry 1,500
Not applicableStudy completedNCT00213733
What this trial is testing

Molecular Assessment of Lymph Nodes in Patients With Resected (Stage I to IIIA) Non-small Cell Lung Cancer

Who this might be right for
Lung Cancer
University Hospital, Strasbourg, France 150
Next Page